Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.05
-0.21 (-3.35%)
May 20, 2026, 9:50 AM EDT - Market open
Gyre Therapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Gyre Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $18.67. The average 1-year stock price forecast is 208.60% higher than the current stock price, while the lowest is $18 (+197.52%) and the highest is $20 (+230.58%).
Price Target: $18.67 (+208.60%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 10, 2025.
Analyst Ratings
The average analyst rating for Gyre Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|
| Strong Buy | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +164.46% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +197.52% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
139.77M
from 116.59M
Increased by 19.88%
Revenue Next Year
135.30M
from 139.77M
Decreased by -3.20%
EPS This Year
-0.33
from 0.02
EPS Next Year
-0.20
from -0.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 207.9M | 168.2M | ||||||
| Avg | 139.8M | 135.3M | ||||||
| Low | 100.0M | 103.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 78.3% | 20.3% | ||||||
| Avg | 19.9% | -3.2% | ||||||
| Low | -14.3% | -26.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.22 | -0.20 | |
| Avg | -0.33 | -0.20 | |
| Low | -0.41 | -0.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.